Click on image to view larger version.

Figure 5 Technetium-99m Tetrofosmin SPECT Polar Maps at Baseline and 3 and 12 Months After Cell Therapy

Technetium-99m tetrofosmin single-photon emission computed tomography polar maps of a patient with stress-induced ischemia in the inferolateral myocardium at baseline (left). Three months after intramyocardial injection of autologous bone-marrow-derived mononuclear cells there is a reduction in the extent of stress-induced ischemia (middle). The effect is sustained at 12 months follow-up (right). Reprinted from Beeres et al. (31), with permission.